Increase in antideoxyribonucleic acid antibody titer in postpartum aggravation of autoimmune thyroid disease. 1988

J Tachi, and N Amino, and Y Iwatani, and H Tamaki, and M Mori, and M Aozasa, and O Tanizawa, and K Miyai
Department of Laboratory Medicine, Osaka University Medical School, Japan.

Serum antidouble stranded DNA antibody levels were measured during pregnancy and after delivery in women who had postpartum exacerbations of Graves' and Hashimoto's diseases. The changes in serum anti-DNA antibody levels closely paralleled those in the serum free T4 index, significantly increasing in the thyrotoxic phase 3-8 months postpartum in women with postpartum exacerbations of thyrotoxicosis due to Graves' disease and 1-3 months postpartum in women with postpartum destructive thyrotoxicosis of Graves' and Hashimoto's diseases. No change in anti-DNA antibody level was found in women with no postpartum exacerbations of thyroid diseases, nor could we demonstrate significant increases in serum anti-DNA antibody titers in patients with thyrotoxicosis due to subacute thyroiditis or in normal pregnant and postpartum women. The changes in serum anti-DNA antibody titers may reflect some generalized immunological abnormality in women who have postpartum exacerbations of Graves' or Hashimoto's diseases.

UI MeSH Term Description Entries
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011644 Puerperal Disorders Disorders or diseases associated with PUERPERIUM, the six-to-eight-week period immediately after PARTURITION in humans. Disorder, Puerperal,Disorders, Puerperal,Puerperal Disorder
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D005260 Female Females
D006111 Graves Disease A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy). Basedow's Disease,Exophthalmic Goiter,Goiter, Exophthalmic,Graves' Disease,Basedow Disease,Hyperthyroidism, Autoimmune,Basedows Disease,Disease, Basedow,Disease, Basedow's,Disease, Graves,Disease, Graves',Exophthalmic Goiters,Goiters, Exophthalmic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000974 Antibodies, Antinuclear Autoantibodies directed against various nuclear antigens including DNA, RNA, histones, acidic nuclear proteins, or complexes of these molecular elements. Antinuclear antibodies are found in systemic autoimmune diseases including systemic lupus erythematosus, Sjogren's syndrome, scleroderma, polymyositis, and mixed connective tissue disease. Anti-DNA Antibodies,Antibodies, Anti-DNA,Antinuclear Antibodies,Antinuclear Autoantibodies,Antinuclear Autoantibody,Antinuclear Factors,Antinuclear Antibody,Antinuclear Factor,Anti DNA Antibodies,Antibody, Antinuclear,Autoantibody, Antinuclear,Factor, Antinuclear
D013967 Thyroiditis, Autoimmune Inflammatory disease of the THYROID GLAND due to autoimmune responses leading to lymphocytic infiltration of the gland. It is characterized by the presence of circulating thyroid antigen-specific T-CELLS and thyroid AUTOANTIBODIES. The clinical signs can range from HYPOTHYROIDISM to THYROTOXICOSIS depending on the type of autoimmune thyroiditis. Autoimmune Thyroiditis,Thyroiditis, Lymphocytic,Thyroiditis, Lymphomatous,Autoimmune Thyroiditides,Lymphocytic Thyroiditides,Lymphocytic Thyroiditis,Lymphomatous Thyroiditides,Lymphomatous Thyroiditis,Thyroiditides, Autoimmune,Thyroiditides, Lymphocytic,Thyroiditides, Lymphomatous
D013971 Thyrotoxicosis A hypermetabolic syndrome caused by excess THYROID HORMONES which may come from endogenous or exogenous sources. The endogenous source of hormone may be thyroid HYPERPLASIA; THYROID NEOPLASMS; or hormone-producing extrathyroidal tissue. Thyrotoxicosis is characterized by NERVOUSNESS; TACHYCARDIA; FATIGUE; WEIGHT LOSS; heat intolerance; and excessive SWEATING. Thyrotoxicoses

Related Publications

J Tachi, and N Amino, and Y Iwatani, and H Tamaki, and M Mori, and M Aozasa, and O Tanizawa, and K Miyai
July 1999, Thyroid : official journal of the American Thyroid Association,
J Tachi, and N Amino, and Y Iwatani, and H Tamaki, and M Mori, and M Aozasa, and O Tanizawa, and K Miyai
January 1989, Autoimmunity,
J Tachi, and N Amino, and Y Iwatani, and H Tamaki, and M Mori, and M Aozasa, and O Tanizawa, and K Miyai
March 1987, The Journal of clinical endocrinology and metabolism,
J Tachi, and N Amino, and Y Iwatani, and H Tamaki, and M Mori, and M Aozasa, and O Tanizawa, and K Miyai
August 1990, The Journal of clinical endocrinology and metabolism,
J Tachi, and N Amino, and Y Iwatani, and H Tamaki, and M Mori, and M Aozasa, and O Tanizawa, and K Miyai
January 1996, Zeitschrift fur Geburtshilfe und Neonatologie,
J Tachi, and N Amino, and Y Iwatani, and H Tamaki, and M Mori, and M Aozasa, and O Tanizawa, and K Miyai
February 2016, The Journal of dermatology,
J Tachi, and N Amino, and Y Iwatani, and H Tamaki, and M Mori, and M Aozasa, and O Tanizawa, and K Miyai
February 1968, American journal of obstetrics and gynecology,
J Tachi, and N Amino, and Y Iwatani, and H Tamaki, and M Mori, and M Aozasa, and O Tanizawa, and K Miyai
January 1993, Ryoikibetsu shokogun shirizu,
J Tachi, and N Amino, and Y Iwatani, and H Tamaki, and M Mori, and M Aozasa, and O Tanizawa, and K Miyai
May 2006, Nihon rinsho. Japanese journal of clinical medicine,
J Tachi, and N Amino, and Y Iwatani, and H Tamaki, and M Mori, and M Aozasa, and O Tanizawa, and K Miyai
December 2000, Endocrine journal,
Copied contents to your clipboard!